{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:28:32Z","timestamp":1769128112761,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10557-018-6819-5","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T06:16:54Z","timestamp":1534486614000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels"],"prefix":"10.1007","volume":"32","author":[{"given":"Sebastian","family":"Bunte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Behmenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Bongartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stroethoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Raupach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Heinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Philipp","family":"Minol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnar","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan U.","family":"Sixt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"issue":"5","key":"6819_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124\u201336.","journal-title":"Circulation"},{"issue":"8866","key":"6819_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0140-6736(93)91819-8","volume":"342","author":"DM Yellon","year":"1993","unstructured":"Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342(8866):276\u20137.","journal-title":"Lancet"},{"issue":"1","key":"6819_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1871523015666160719155122","volume":"15","author":"E Santillo","year":"2016","unstructured":"Santillo E, Migale M, Postacchini D, Balestrini F, Incalzi RA. Cardioprotection by conditioning mimetic drugs. Antiinflamm Antiallergy Agents Med Chem. 2016;15(1):15\u201330.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"2","key":"6819_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1124\/jpet.104.074476","volume":"312","author":"CM Cao","year":"2005","unstructured":"Cao CM, Xia Q, Gao Q, Chen M, Wong TM. Calcium-activated Potassium Channel triggers Cardioprotection of ischemic preconditioning. J Pharmacol Exp Ther. 2005;312(2):644\u201350.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"6819_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2152\/jmi.63.80","volume":"63","author":"M Kinoshita","year":"2016","unstructured":"Kinoshita M, Tsutsumi YM, Fukuta K, Kasai A, Tanaka K. Isoflurane-induced postconditioning via mitochondrial calcium-activated potassium channels. J Med Investig. 2016;63(1\u20132):80\u20134.","journal-title":"J Med Investig"},{"issue":"4","key":"6819_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejcts.2010.11.044","volume":"39","author":"PP Caimmi","year":"2011","unstructured":"Caimmi PP, Molinari C, Uberti F, Micalizzi E, Valente G, Mary DA, et al. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Eur J Cardiothorac Surg. 2011;39(4):59\u201367.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"6819_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","volume":"159","author":"Z Papp","year":"2012","unstructured":"Papp Z, Edes I, Fruhwald S, De Hert SG, Salmenpera M, Leppikangas H, et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012;159(2):82\u20137.","journal-title":"Int J Cardiol"},{"issue":"5","key":"6819_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bja\/aeq213","volume":"105","author":"R Huhn","year":"2010","unstructured":"Huhn R, Heinen A, Weber NC, Schlack W, Preckel B, Hollmann MW. Ischaemic and morphine-induced post-conditioning: impact of mK(ca) channels. Brit J Anaesth. 2010;105(5):589\u201395.","journal-title":"Brit J Anaesth"},{"issue":"12","key":"6819_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144737","volume":"10","author":"F Behmenburg","year":"2015","unstructured":"Behmenburg F, Dorsch M, Huhn R, Mally D, Heinen A, Hollmann MW, et al. Impact of mitochondrial Ca2+-sensitive potassium (mBKCa) channels in sildenafil-induced Cardioprotection in rats. PLoS One. 2015;10(12):e0144737.","journal-title":"PLoS One"},{"issue":"7","key":"6819_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0028-3908(96)00137-2","volume":"35","author":"M Sanchez","year":"1996","unstructured":"Sanchez M, McManus OB. Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel. Neuropharmacology. 1996;35(7):963\u20138.","journal-title":"Neuropharmacology"},{"issue":"1","key":"6819_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2007.10.006","volume":"44","author":"X Wang","year":"2008","unstructured":"Wang X, Fisher PW, Xi L, Kukreja RC. Essential role of mitochondrial Ca2+\u2212activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection. J Mol Cell Cardiol. 2008;44(1):105\u201313.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"6819_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1085\/jgp.201411259","volume":"144","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Lingle CJ. Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism. J Gen Physiol. 2014;144(5):415\u201340.","journal-title":"J Gen Physiol"},{"issue":"8","key":"6819_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12630-010-9325-1","volume":"57","author":"J Frassdorf","year":"2010","unstructured":"Frassdorf J, Huhn R, Niersmann C, Weber NC, Schlack W, Preckel B, et al. Morphine induces preconditioning via activation of mitochondrial K(ca) channels. Can J Anaesth. 2010;57(8):767\u201373.","journal-title":"Can J Anaesth"},{"issue":"1","key":"6819_CR14","doi-asserted-by":"publisher","first-page":"H131","DOI":"10.1152\/ajpheart.2002.282.1.H131","volume":"282","author":"K Brixius","year":"2002","unstructured":"Brixius K, Reicke S, Schwinger RH. Beneficial effects of the ca(2+) sensitizer levosimendan in human myocardium. Am J Physiol Heart Circ Physiol. 2002;282(1):H131\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"6819_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0306-3623(95)02060-8","volume":"27","author":"L Virag","year":"1996","unstructured":"Virag L, Hala O, Marton A, Varro A, Papp JG. Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer. Gen Pharmacol. 1996;27(3):551\u20136.","journal-title":"Gen Pharmacol"},{"issue":"3","key":"6819_CR16","first-page":"125","volume":"17","author":"R Levin","year":"2012","unstructured":"Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol. 2012;17(3):125\u201330.","journal-title":"Exp Clin Cardiol"},{"issue":"2","key":"6819_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1074248406289286","volume":"11","author":"JG Papp","year":"2006","unstructured":"Papp JG, Pollesello P, Varro AF, Vegh AS. Effect of levosimendan and milrinone on regional myocardial ischemia\/reperfusion-induced arrhythmias in dogs. J Cardiovasc Pharmacol Ther. 2006;11(2):129\u201335.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"6819_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.fjc.0000246151.39758.2a","volume":"48","author":"I Lepran","year":"2006","unstructured":"Lepran I, Pollesello P, Vajda S, Varro A, Papp JG. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol. 2006;48(4):148\u201352.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5595","key":"6819_CR19","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1074360","volume":"298","author":"W Xu","year":"2002","unstructured":"Xu W, Liu Y, Wang S, McDonald T, Van Eyk JE, Sidor A, et al. Cytoprotective role of Ca2+\u2212 activated K+ channels in the cardiac inner mitochondrial membrane. Science. 2002;298(5595):1029\u201333.","journal-title":"Science"},{"issue":"4","key":"6819_CR20","first-page":"30","volume":"16","author":"RC Kukreja","year":"2011","unstructured":"Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Exp Clin Cardiol. 2011;16(4):30\u20135.","journal-title":"Exp Clin Cardiol"},{"issue":"4","key":"6819_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-6997(24)01469-8","volume":"52","author":"CC Shieh","year":"2000","unstructured":"Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52(4):557\u201394.","journal-title":"Pharmacol Rev"},{"issue":"24","key":"6819_CR22","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1523\/JNEUROSCI.21-24-09585.2001","volume":"21","author":"H Hu","year":"2001","unstructured":"Hu H, Shao LR, Chavoshy S, Gu N, Trieb M, Behrens R, et al. Presynaptic Ca2+\u2212activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci. 2001;21(24):9585\u201397.","journal-title":"J Neurosci"},{"issue":"5","key":"6819_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/1074248416687873","volume":"22","author":"S Aggarwal","year":"2017","unstructured":"Aggarwal S, Randhawa PK, Singh N, Jaggi AS. Role of ATP-sensitive potassium channels in remote ischemic preconditioning induced tissue protection. J Cardiovasc Pharmacol Ther. 2017;22(5):467\u201375.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"6819_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(24)36997-6","volume":"283","author":"H Yokoshiki","year":"1997","unstructured":"Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther. 1997;283(1):375\u201383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"6819_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-200104000-00003","volume":"37","author":"P Kaheinen","year":"2001","unstructured":"Kaheinen P, Pollesello P, Levijoki J, Haikala H. Levosimendan increases diastolic coronary flow in isolated Guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol. 2001;37(4):367\u201374.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"6819_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/j.jvca.2009.01.016","volume":"23","author":"M Lange","year":"2009","unstructured":"Lange M, Redel A, Smul TM, Lotz C, Nefzger T, Stumpner J, et al. Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta 2-adrenergic receptors. J Cardiothorac Vasc Anesth. 2009;23(5):607\u201313.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"6819_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1053\/j.jvca.2010.07.018","volume":"25","author":"TM Smul","year":"2011","unstructured":"Smul TM, Stumpner J, Blomeyer C, Lotz C, Redel A, Lange M, et al. Propofol inhibits desflurane-induced preconditioning in rabbits. J Cardiothorac Vasc Anesth. 2011;25(2):276\u201381.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"6819_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.RES.72.1.44","volume":"72","author":"JD Thornton","year":"1993","unstructured":"Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res. 1993;72(1):44\u20139.","journal-title":"Circ Res"},{"key":"6819_CR29","doi-asserted-by":"publisher","first-page":"H1630","DOI":"10.1152\/ajpheart.2001.281.4.H1630","volume":"281","author":"D Schulman","year":"2001","unstructured":"Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2001;281:H1630\u2013H6.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"6819_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/pr.107.06002","volume":"59","author":"P Ferdinandy","year":"2007","unstructured":"Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007;59(4):418\u201358.","journal-title":"Pharmacol Rev"},{"key":"6819_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.exger.2014.03.029","volume":"56","author":"A Heinen","year":"2014","unstructured":"Heinen A, Strothoff M, Schmidt A, Stracke N, Behmenburg F, Bauer I, et al. Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BK(ca) signaling pathway. Exp Gerontol. 2014;56:99\u2013105.","journal-title":"Exp Gerontol"},{"issue":"4","key":"6819_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/ALN.0b013e318167af2d","volume":"108","author":"Y Mio","year":"2008","unstructured":"Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, et al. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology. 2008;108(4):612\u201320.","journal-title":"Anesthesiology"},{"issue":"1","key":"6819_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.exger.2011.11.003","volume":"47","author":"R Huhn","year":"2012","unstructured":"Huhn R, Weber NC, Preckel B, Schlack W, Bauer I, Hollmann MW, et al. Age-related loss of cardiac preconditioning: impact of protein kinase a. Exp Gerontol. 2012;47(1):116\u201321.","journal-title":"Exp Gerontol"},{"issue":"5","key":"6819_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11055-007-0040-5","volume":"37","author":"MM Galagudza","year":"2007","unstructured":"Galagudza MM, Nekrasova MK, Syrenskii AV, Nifontov EM. Resistance of the myocardium to ischemia and the efficacy of ischemic preconditioning in experimental diabetes mellitus. Neurosci Behav Physiol. 2007;37(5):489\u201393.","journal-title":"Neurosci Behav Physiol"},{"issue":"10","key":"6819_CR35","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s00125-004-1514-4","volume":"47","author":"SB Kristiansen","year":"2004","unstructured":"Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, et al. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia. 2004;47(10):1716\u201321.","journal-title":"Diabetologia"},{"key":"6819_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-11-4","volume":"11","author":"S Matsumoto","year":"2012","unstructured":"Matsumoto S, Cho S, Tosaka S, Higashijima U, Maekawa T, Hara T, et al. Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts. Cardiovasc Diabetol. 2012;11:4.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-018-6819-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T11:15:32Z","timestamp":1751800532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-018-6819-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["6819"],"URL":"https:\/\/doi.org\/10.1007\/s10557-018-6819-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"17 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}